{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:03:36Z","timestamp":1792710216248,"version":"4.5.0"},"reference-count":35,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Mutation"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1002\/humu.22910","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T10:10:01Z","timestamp":1443521401000},"page":"43-51","source":"Crossref","is-referenced-by-count":58,"title":["Functional and Clinical Consequences of Novel \u03b1-Galactosidase A Mutations in Fabry Disease"],"prefix":"10.1155","volume":"37","author":[{"given":"Jan","family":"Lukas","sequence":"first","affiliation":[{"name":"Albrecht-Kossel-Institute for Neuroregeneration; Medical University Rostock; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Scalia","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine and Molecular Immunology \u201cA. Monroy\u201d (IBIM); National Research Council (CNR); Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Eichler","sequence":"additional","affiliation":[{"name":"Centogene AG; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Pockrandt","sequence":"additional","affiliation":[{"name":"Albrecht-Kossel-Institute for Neuroregeneration; Medical University Rostock; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Dehn","sequence":"additional","affiliation":[{"name":"Albrecht-Kossel-Institute for Neuroregeneration; Medical University Rostock; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cozma","sequence":"additional","affiliation":[{"name":"Centogene AG; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Katrin","family":"Giese","sequence":"additional","affiliation":[{"name":"Albrecht-Kossel-Institute for Neuroregeneration; Medical University Rostock; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[{"name":"Albrecht-Kossel-Institute for Neuroregeneration; Medical University Rostock; Rostock Germany"},{"name":"Centogene AG; Rostock Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"10.1002\/humu.22910-BIB0001|humu22910-cit-0001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1002\/humu.22910-BIB0002|humu22910-cit-0002","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/01.WNL.0000166000.24321.4F","article-title":"Effect of genetic modifiers on cerebral lesions in Fabry disease","volume":"64","author":"Altarescu","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/humu.22910-BIB0035|humu22910-cit-0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1750-1172-6-66","article-title":"Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests","volume":"6","author":"Andreotti","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1002\/humu.22910-BIB0003|humu22910-cit-0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","article-title":"Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study-screening genetic conditions in Portuguese young stroke patients","volume":"41","author":"Baptista","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/humu.22910-BIB0004|humu22910-cit-0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-0004.2009.01345.x","article-title":"Does geographical location influence the phenotype of Fabry disease in women in Europe","volume":"77","author":"Barba-Romero","year":"2010","journal-title":"Clin Genet"},{"key":"10.1002\/humu.22910-BIB0005|humu22910-cit-0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1756-0500-4-323","article-title":"Genetic screening of Fabry patients with EcoTILLING and HRM technology","volume":"4","author":"Bono","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1002\/humu.22910-BIB0006|humu22910-cit-0006","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","article-title":"Belgian Fabry study: prevalence of fabry disease in a cohort of 1000 young patients with cerebrovascular disease","volume":"41","author":"Brouns","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/humu.22910-BIB0007|humu22910-cit-0007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1750-1172-8-111","article-title":"Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones Orphanet","volume":"8","author":"Cammisa","year":"2013","journal-title":"J Rare Dis"},{"key":"10.1002\/humu.22910-BIB0008|humu22910-cit-0008","first-page":"3733","volume-title":"In The metabolic and molecular bases of inherited disease","author":"Desnick","year":"2001"},{"key":"10.1002\/humu.22910-BIB0009|humu22910-cit-0009","article-title":"X chromosome inactivation in female patients with Fabry disease","author":"Echevarria","year":"2015","journal-title":"Clin Genet"},{"key":"10.1002\/humu.22910-BIB0033|humu22910-cit-0033","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes","volume":"3","author":"Eng","year":"1997","journal-title":"Mol Med"},{"key":"10.1002\/humu.22910-BIB0010|humu22910-cit-0010","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","article-title":"Active-site-specific chaperone therapy for Fabry disease: Yin and Yang of enzyme inhibitors","volume":"274","author":"Fan","year":"2007","journal-title":"FEBS J"},{"key":"10.1002\/humu.22910-BIB0011|humu22910-cit-0011","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ymgme.2014.11.004","article-title":"The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies","volume":"114","author":"Ferreira","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22910-BIB0012|humu22910-cit-0012","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF03402156","article-title":"Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classic and variant phenotypes","volume":"8","author":"Germain","year":"2002","journal-title":"Mol Med"},{"key":"10.1002\/humu.22910-BIB0013|humu22910-cit-0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry Disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1002\/humu.22910-BIB0014|humu22910-cit-0014","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1136\/jmg.40.4.e38","article-title":"Clinical presentation in female patients with Fabry disease","volume":"40","author":"Guffon","year":"2003","journal-title":"J Med Genet"},{"key":"10.1002\/humu.22910-BIB0015|humu22910-cit-0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.chembiol.2011.10.012","article-title":"The molecular basis of pharmacological chaperoning in human \u03b1-galactosidase","volume":"18","author":"Guce","year":"2011","journal-title":"Chem Biol"},{"key":"10.1002\/humu.22910-BIB0016|humu22910-cit-0016","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22910-BIB0017|humu22910-cit-0017","doi-asserted-by":"crossref","first-page":"e55565","DOI":"10.1371\/journal.pone.0055565","article-title":"Multifocal white matter lesions associated with the D313Y mutation of the \u03b1-galactosidase A gene","volume":"8","author":"Lenders","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/humu.22910-BIB0018|humu22910-cit-0018","doi-asserted-by":"crossref","first-page":"e1003632","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1002\/humu.22910-BIB0036|humu22910-cit-0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/humu.22910-BIB0019|humu22910-cit-0019","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymgme.2012.07.003","article-title":"Mutant \u03b1-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level","volume":"107","author":"Mitobe","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1002\/humu.22910-BIB0020|humu22910-cit-0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneur.63.3.453","article-title":"Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome","volume":"63","author":"Nance","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1002\/humu.22910-BIB0021|humu22910-cit-0021","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22910-BIB0022|humu22910-cit-0022","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2012_154","article-title":"Lyso-Gb3 indicates that the alpha-galactosidase A mutation D313Y is not clinically relevant for Fabry disease","volume":"7","author":"Niemann","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1002\/humu.22910-BIB0023|humu22910-cit-0023","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/humu.22910-BIB0024|humu22910-cit-0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cge.12449","article-title":"Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance","volume":"88","author":"Smid","year":"2015","journal-title":"Clin Genet"},{"key":"10.1002\/humu.22910-BIB0025|humu22910-cit-0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J Med Genet"},{"key":"10.1002\/humu.22910-BIB0026|humu22910-cit-0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.22910-BIB0027|humu22910-cit-0027","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ymgmr.2014.07.005","article-title":"Plasma mutant \u03b1-galactosidase A protein and globotriaosylsphingosine level in Fabry disease","volume":"1","author":"Tsukimura","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1002\/humu.22910-BIB0028|humu22910-cit-0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"der Tol","year":"2014","journal-title":"J Med Genet"},{"key":"10.1002\/humu.22910-BIB0029|humu22910-cit-0029","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1002\/humu.22910-BIB0030|humu22910-cit-0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_130","article-title":"Newborn screening for lysosomal storage disorders in hungary","volume":"6","author":"Wittmann","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1002\/humu.22910-BIB0031|humu22910-cit-0031","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/humu.21530","article-title":"A pharmacogenetic approach to identify mutant forms of \u03b1-galactosidase A that respond to a pharmacological chaperone for Fabry disease","volume":"32","author":"Wu","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22910-BIB0032|humu22910-cit-0032","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum Mutat"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.22910","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.22910\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:53:36Z","timestamp":1672332816000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.22910"}},"subtitle":["HUMAN MUTATION"],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.22910","archive":["Portico"],"relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10,27]]}}}